George Budwell
George Budwell, Ph.D., is a contributing Biotechnology and Technology Analyst at The Motley Fool, covering disruptive innovators in healthcare, defense, and artificial intelligence, and writing on portfolio theory, dividend stocks, and value investing. Prior to The Motley Fool, George was a freelance medical and science writer for various organizations, as well as an independent consultant for multiple life sciences-oriented hedge funds. In a former life, he was an evolutionary biologist, having completed two postdoctoral fellowships at Kyoto University and Illinois State University, respectively. He holds a Ph.D. in Evolutionary Biology from Tulane University and a B.S. (pre-med) from Loyola University. Fun fact: George is an avid golfer, nature enthusiast, and proud father of four.
Recent Articles by George Budwell

2 Tech Stocks I'd Buy and Never Sell

2 Incredible Growth Stocks I'd Buy Right Now

3 AI Stocks That Could Be Hidden Gems

3 Growth Stocks I'm Loading Up On

3 Robotics Stocks to Buy Hand Over Fist

7 Space Stocks I'd Buy Without Hesitation

5 AI Stocks Every Investor Should Own

Is Oscar Health Stock Still a Buy?

Better Core AI Stock: Nvidia or Palantir Technologies?

Better Growth Stock: Rocket Lab USA vs. Datadog
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.